FDA Investigator Ankur C Patel
Ankur C Patel has inspections in 1 countries as of 29 Aug 2023. Ankur C Patel has collaborated with a combined 1775 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
18
Last Inspection Date:
29 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Addam S Reynolds,
Adetutu M Gidado,
Alice S Tsao,
Amy L Singer,
Amy M Cramer,
Annemarie Bodnar,
Atul J Agrawal,
Barbara J Wilimczyk,
Barbara Jwilimczyk Macri,
Christina K Theodorou,
Christine M Cerenzio,
Craig D Zagata,
Daniel J Grabicki,
Daniel J Min,
David A Oluwo,
Dawn L Wydner,
Denise M Digiulio,
Devon Jenkins,
Douglas C Kovacs,
Elaine E Gilfillan,
Emest F Bizjak,
Emmanuel J Ramos,
Eric Rothschild,
Erin D Mccaffery,
Frank J Marciniak,
Frederick Razzaghi,
George Pyramides,
Guerlain Ulysse,
Helen B Ricalde,
Helen Verdel,
James M Mason,
James Norman,
James R Birkenstamm,
Janet A Rajan,
Jessica S Estriplet,
Jogy George,
Jose M Cayuela,
Joy Rkozlowski Klena,
Karen E D'orazio,
Karen F Tomaziefski,
Keith M Reilly,
Kelli F Dobilas,
Kelli Regente,
Ko U Min,
Kristina J Donohue,
Kristy A Zielny,
Lata C Mathew, PhD,
Lauren L Vajo,
Lawrence Harmon, Jr,
LCDR Susan E Polifko,
Li Li,
Liatte Kreuger, PharmD,
Lisa M Bellows,
Lisa Relloos,
Loretta Nemchik,
Marcellinus D Dordunoo,
Marea K Harmon,
Margaret M Sands,
Maria Estrella,
Melissa T Roy,
Michael R Klapal,
Michael Serrano,
Monika Borkowska,
Nancy F Scheraga,
Nancy M Espinal,
Nerizza B Guerin,
Nicholas A Violand,
Niketa Patel,
Nina Yang,
Odera I Ekwunife,
Paul L Bellamy,
Pushpa S Jayasekara,
Rachel C Harrington,
Regina T Brown,
Robert D Tollefsen,
Robin P Mathew,
Rose Ljean Mary,
Rose Xu,
Russell J Glapion,
Sachinkumar V Patel,
Saleem A Akhtar,
Sarah Forney,
Satheesh Thomas,
Sayyem H Akbar,
Simone E Pitts,
Sinai Davis,
Sony Mathews,
Stephen J Koniers,
Stephen J Mottola,
Susan M Halsted,
Syeda N Mahazabin,
Tamil Arasu, PhD,
Tanya R Syffrard,
Tara G Bizjak,
Tara R Gooen,
Tarun D Mehta,
Thomas E Friel,
Tiffani D Wilson,
Unnee Ranjan,
Xiaohan Cai, PhD,
Ying Zhang,
Yvesna C Blaise,
Yvins Dezan,
Zakaria I Ganiyu
Ankur C Patel's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more